Healthcare Industry Veteran Added to Accelerate Commercialization and Market Expansion

Beverly, MA – June 17, 2026 – LeviSense Medical, Inc., developer of the Pro-Daptive™ SensorCell™ Flotation System, a next-generation therapeutic support surface technology for the prevention and treatment of pressure injuries, is pleased to announce the appointment of Shri Parikh as Chief Executive Officer and Board Director. .

With more than 30 years in healthcare, Parikh has successfully developed and introduced innovative technologies to market while building relationships with major health systems, clinicians, and industry leaders. His career spans across organizations in wound care, life science, orthopedic and cardiovascular medical devices with a range of leadership positions at  Molnlycke Health Care, Sanuwave Health, Stryker, Abbott/St. Jude Medical, Bristol-Myers Squibb, and Milliken & Company.  .

Most recently, Parikh served as Executive Vice President and President of Milliken’s Healthcare business, OVIK Health, where he led a strategic transformation that expanded the business and increased profitability over 350 percent.

“Shri brings the experience, industry relationships, and commercial leadership needed for this stage of our development,” said David Bertoni, Co-Founder and COO of LeviSense Medical. “His addition strengthens our ability to expand market adoption, as we continue to invest  in innovation, and build long-term shareholder value.”

“Few opportunities offer the combination of differentiated technology, strong market demand, and the potential to improve patient care at scale,” said Parikh. “LeviSense has built a strong foundation of innovation and culture around patient centricity, and I am thrilled to be in this position to help  the Company  capture its full commercial potential.”

About LeviSense Medical, Inc.:

LeviSense Medical, Inc. is a Boston-area medical technology company commercializing the Pro-Daptive™ SensorCell™ Flotation System, a next-generation therapeutic support surface designed to reduce the hardships of being bedridden for patients and their caregivers. The Company’s SensorCell™ platform advances immersion, envelopment, and pressure management technologies for the prevention and treatment of pressure injuries across the continuum of care.